Global real-life evidence study on the long-term effectiveness of duodopa (solution) for infusion in advanced Parkinson's disease in routine clinical practice (ROSSINI: Real-life results with continuous subcutaneous infusion)
OBSERVATIONAL STUDY WITH MEDICATION
Clinical trial information
- Promoter: ABBVIE SPAIN SLU
- Execution start: 21/12/2023
- End of execution: 30/11/2028
- PI: FRANCISCO ESCAMILLA SEVILLA
